Impact BioMedical, Inc. (IBO)
Impact BioMedical will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$3.00 - $5.00
Shares Offered
1,500,000
Deal Size
$6.00M
Impact BioMedical Statistics
Total Valuation
IBO has a market cap or net worth of $46.00 million. The enterprise value is $57.38 million.
Market Cap | 46.00M |
Enterprise Value | 57.38M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
IBO has 11.50 million shares outstanding.
Shares Outstanding | 11.50M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.56 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.40 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -16.19 |
Financial Efficiency
Return on equity (ROE) is -22.01% and return on invested capital (ROIC) is -9.60%.
Return on Equity (ROE) | -22.01% |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | -9.60% |
Revenue Per Employee | n/a |
Profits Per Employee | -$6.46M |
Employee Count | 1 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | -1.88M |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | n/a |
Average Volume (20 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -3.97M |
Pretax Income | -8.34M |
Net Income | -6.46M |
EBITDA | -6.79M |
EBIT | -7.90M |
Earnings Per Share (EPS) | -$0.56 |
Balance Sheet
The company has $405,000 in cash and $11.78 million in debt, giving a net cash position of -$11.38 million or -$0.99 per share.
Cash & Cash Equivalents | 405,000 |
Total Debt | 11.78M |
Net Cash | -11.38M |
Net Cash Per Share | -$0.99 |
Equity (Book Value) | 29.58M |
Book Value Per Share | 2.57 |
Working Capital | -11.77M |
Cash Flow
In the last 12 months, operating cash flow was -$2.78 million and capital expenditures -$294,000, giving a free cash flow of -$3.08 million.
Operating Cash Flow | -2.78M |
Capital Expenditures | -294,000 |
Free Cash Flow | -3.08M |
FCF Per Share | -$0.27 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
IBO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -14.05% |
FCF Yield | -6.68% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |